Next-Generation Biomanufacturing Market

The rapid maturity of the biopharmaceutical industry shows the growing importance of biomanufacturing as the most basic process for developing and manufacturing bio-based products. With the development of commercialization of biopharmaceuticals and the increase of more products in the development pipeline, biopharmaceutical companies look forward to adopting novel biomanufacturing strategies, focusing on balancing process design, performance and efficiency innovation with speed and cost.

Next-Generation Biomanufacturing Market contains market size and forecasts of Next-Generation Biomanufacturing in Global, including the following market information:

• Global Next-Generation Biomanufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Next-Generation Biomanufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Upstream Biomanufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Next-Generation Biomanufacturing include Merck, Thermo Fisher Scientific, Danaher, Eppendorf, Sartorius, GEA Group, bbi-biotech, Esco Group of Companies and Solaris Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Next-Generation Biomanufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Next-Generation Biomanufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Next-Generation Biomanufacturing Market Segment Percentages, by Type, 2021 (%)

• Upstream Biomanufacturing
• Downstream Biomanufacturing

Global Next-Generation Biomanufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Next-Generation Biomanufacturing Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• CMOs/CDMOs
• Research Institutions

Global Next-Generation Biomanufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Next-Generation Biomanufacturing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Next-Generation Biomanufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Next-Generation Biomanufacturing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Thermo Fisher Scientific
• Danaher
• Eppendorf
• Sartorius
• GEA Group
• bbi-biotech
• Esco Group of Companies
• Solaris Biotechnology
• PBS Biotech
• Applikon Biotechnology
• Meissner Filtration Products
• Shanghai Bailun Biotechnology